id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263840-1t4ykc01	Altay, Ozlem	Current status of COVID-19 therapies and drug repositioning applications	2020-06-20		.txt	text/plain	2099	140	44	Summary The rapid and global spread of a new human coronavirus (SARS-CoV-2) has produced an immediate urgency to discover promising targets for treatment of COVID-19. Here, we review current information concerning the global health issue of COVID-19 including promising approved drugs and ongoing clinical trials for prospective treatment options. At the genome 60 level, SARS-CoV-2 has 79·5% homology to SARS CoVCoV-2 and other coronaviruses, and its relative ease of sample acquisition and study, it has been widely 75 accepted that drug repositioning is a promising approach to make available an effective, safety-assured 76 treatment in a timely manner. In this review, we summarize diagnosis approaches, risk groups, available 77 treatment options, and drug repositioning studies related to COVID-19. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 525 2019 (COVID-19): The experience of clinical immunologists from China	./cache/cord-263840-1t4ykc01.txt	./txt/cord-263840-1t4ykc01.txt